Login
Toggle navigation
Videos
Categories
Trending
Mark Iwicki, chairman and CEO, Kala Pharmaceuticals Inc
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Mark Iwicki, chairman and CEO, Kala Pharmaceuticals Inc
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
As Bitcoin rebounds after a tumultuous year for the crypto industry, Galaxy Digital Founder & CEO Mike Novogratz remains optimistic.
00:10:00
Initiator Pharma A/S, a biotech company based in Århus, Denmark, focuses on developing the drug candidate IPED2015.
00:10:00
Semiconductors and Beyond: Khaldoon Al Mubarak’s Vision for Mubadala’s Global Investments | Khaldoon Al Mubarak - CEO, Mubadala
00:10:00
Andrew Perlman is the CEO of GreatPoint Energy, a company focused on developing clean energy technologies like coal gasification to produce natural gas.
00:10:00
The Steadfast Steward of City of London Investment Trust
00:10:00
Bogdan Badea Discusses Market Insights at Financial Intelligence's Capital Market Forum | Bogdan Nicolae Badea , CEO, S.P.E.E.H. Hidroelectrica SA.
00:10:00
Is It Time for a Financial Advisor? Key Factors with James Conole | James Conole - CFP®
00:00:00
Scancell Holdings' present progression and pipeline plan now firm is fully funded for all programmes - Professor Lindy Durrant (Chief Executive Officer, Chief Scientific Officer), Scancell Holdings
00:10:00
Hybrid Solar Power Enhances Efficiency and Sustainability at Otjikoto Gold Mine
00:10:00
Lassila & Tikanoja CEO's review from 2013 provides an overview of the company's operations and strategic direction.
00:10:00
Fiercely Reliable Structures for Safety and Efficiency
00:10:00
Excelling in West African Gold Mining: The Yaramoko Goldmine Story